首页> 外文期刊>Translational psychiatry. >Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota
【24h】

Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota

机译:益生元对奥氮平诱导的体重增加的衰减作用:中枢和外周生物标志物及肠道菌群的分析

获取原文
获取外文期刊封面目录资料

摘要

Olanzapine is an effective antipsychotic drug but since it causes significant weight gain, it is not well tolerated by psychosis patients. The prebiotic, B-GOS?, attenuates metabolic dysfunction in obese subjects, and in rodents, alters central NMDA receptors and may affect serotonin receptors that are relevant in psychosis. We have determined whether B-GOS? influenced olanzapine-associated weight gain and central NMDA and serotonin receptors. Circulating acetate, IL-1β, IL-8 and TNFα, liver acetyl-CoA carboxylase (ACC), white adipose tissue (WAT) acetate receptor GPR43, and specific faecal bacteria genera were also measured to provide mechanistic information. Adult female Sprague-Dawley rats were administered a B-GOS? (0.5?g/kg/day) solution or water for 21 days, and received a single, daily, intraperitoneal injection of olanzapine or saline on days 8–21. The intake of B-GOS? significantly attenuated olanzapine-induced weight gain without altering frontal cortex 5-HT2AR blockade. Cortical GluN1 levels were elevated by olanzapine in the presence of B-GOS?. Plasma acetate concentrations increased following B-GOS? or olanzapine administration alone, but reduced when prebiotic and drug were administered in combination. This pattern was paralleled by hepatic ACC mRNA expression. The abundance of WAT GPR43 mRNA was reduced by olanzapine, only in the absence of B-GOS?. Co-administration of B-GOS? and olanzapine also elevated plasma TNFα, which is reported to influence lipid metabolism. Finally, B-GOS? elevated faecal Bifidobacterium spp. and reduced some bacteria in the Firmicutes phylum, whilst olanzapine treatment either alone or with B-GOS?, was without effect. These data suggest that inclusion of B-GOS? as an adjunct to olanzapine treatment in schizophrenia may prevent weight gain and have benefits on cognitive function in psychosis. The role of acetate in these effects requires further investigation.
机译:奥氮平是一种有效的抗精神病药物,但由于它会导致体重显着增加,因此精神病患者不能很好地耐受。益生元B-GOS ?减轻肥胖受试者的代谢功能障碍,在啮齿动物中改变中枢NMDA受体,并可能影响与精神病相关的5-羟色胺受体。我们已经确定B-GOS ?是否影响奥氮平相关的体重增加以及中枢NMDA和血清素受体。还测量了循环乙酸盐,IL-1β,IL-8和TNFα,肝乙酰辅酶A羧化酶(ACC),白色脂肪组织(WAT)乙酸盐受体GPR43和特定的粪便细菌属,以提供机制信息。成年雌性Sprague-Dawley大鼠接受B-GOS ?(0.5?g / kg /天)溶液或水21天,并接受每日一次腹膜内注射奥氮平或生理盐水。第8-21天。摄入B-GOS ?可以显着减轻olanzapine引起的体重增加,而不会改变额叶皮层5-HT2AR的阻滞作用。在B-GOS ?存在下,奥氮平可提高皮质GluN1水平。单独使用B-GOS ?或奥氮平后,血浆乙酸盐浓度会增加,但是当组合使用益生元和药物时,血浆乙酸盐浓度会降低。该模式与肝ACC mRNA表达平行。只有在没有B-GOS ?的情况下,奥氮平才能降低WAT GPR43 mRNA的丰度。 B-GOS ?和奥氮平的共同给药也会升高血浆TNFα,据报道会影响脂质代谢。最后,B-GOS ?升高了粪便双歧杆菌的种类。并减少了Firmicutes门上的一些细菌,而单独或联合B-GOS ?进行奥氮平治疗无效。这些数据表明,在精神分裂症中加入B-GOS ?作为奥氮平治疗的辅助剂可能会预防体重增加,并有益于精神病的认知功能。乙酸盐在这些作用中的作用需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号